L&C Bio Co Ltd
KOSDAQ:290650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Wuhan Raycus Fiber Laser Technologies Co Ltd
SZSE:300747
|
CN |
|
GGL Resources Corp.
OTC:GGLXF
|
CA |
L&C Bio Co Ltd
Operating Expenses
L&C Bio Co Ltd
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
Operating Expenses
-₩39.9B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Operating Expenses
-₩1.3T
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-26%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Operating Expenses
-₩199.4B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Operating Expenses
-₩36.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Operating Expenses
-₩58.7B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-33%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Operating Expenses
-₩119.7B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
L&C Bio Co Ltd
Glance View
L&C BIO Co., Ltd. develops soft tissue, allografts, and medical devices. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-11-01. The firm mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The firm also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.
See Also
What is L&C Bio Co Ltd's Operating Expenses?
Operating Expenses
-39.9B
KRW
Based on the financial report for Sep 30, 2025, L&C Bio Co Ltd's Operating Expenses amounts to -39.9B KRW.
What is L&C Bio Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-31%
Over the last year, the Operating Expenses growth was -27%. The average annual Operating Expenses growth rates for L&C Bio Co Ltd have been -32% over the past three years , -31% over the past five years .
